BIO-TECHNE Corp — Director's Dealing 2022

Oct 31, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-10-27

Reporting Person: VESSEY RUPERT (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-27	Common Stock	A	338	—	Acquired	1565	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-27	Stock Options (Right to Buy)	$295.77	A	865	Acquired	2032-10-27	Common Stock (865)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$209.26	2029-10-25	Common Stock (588)	588	Direct
Stock Options (Right to Buy)	$201.64	2029-10-24	Common Stock (2011)	2011	Direct
Stock Options (Right to Buy)	$255.69	2030-10-29	Common Stock (1507)	1507	Direct
Stock Options (Right to Buy)	$515.24	2031-10-28	Common Stock (633)	633	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.